Otolaryngologists and their role in vaccination for prevention of HPV associated head & neck cancer

References

• Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M. Human papillomavirus-associated cancers - United States, 2008-2012. MMWR Morbid Mortal Weekly Rep. 2016;65(26):661–666. doi:10.15585/mmwr.mm6526a1.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–4301. doi:10.1200/JCO.2011.36.4596.
   PubMed Web of Science ®Google Scholar
• Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer. 2009;125(2):362–366. doi:10.1002/ijc.24339.
   PubMed Web of Science ®Google Scholar
• How Many Cancers Are Linked with HPV Each Year? [accessed 2018 Jul 27]. https://www.cdc.gov/cancer/hpv/statistics/cases.htm.
   Google Scholar
• D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–1956. doi:10.1056/NEJMoa065497.
   PubMed Web of Science ®Google Scholar
• Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PloS one. 2013;8(7):e68329. doi:10.1371/journal.pone.0068329.
   PubMed Web of Science ®Google Scholar
• Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781–789. doi:10.1016/S1470-2045(10)70017-6.
   PubMed Web of Science ®Google Scholar
• Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, et al. NCCN guidelines insights: head and neck cancers, version 1.2018. J Natl Compr Cancer Network: JNCCN. 2018;16(5):479–490. doi:10.6004/jnccn.2018.0026.
   PubMed Web of Science ®Google Scholar
• Huang SH, O’Sullivan B. Overview of the 8th Edition TNM classification for head and neck cancer. Curr Treat Options Oncol. 2017;18(7):40. doi:10.1007/s11864-017-0484-y.
   PubMed Web of Science ®Google Scholar
• O’Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, Lee N, Riaz N, Pei X, Koyfman SA, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the international collaboration on oropharyngeal cancer network for staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17(4):440–451. doi:10.1016/S1470-2045(15)00560-4.
   PubMed Web of Science ®Google Scholar
• Marur S, Li S, Cmelak AJ, Gillison ML, Zhao WJ, Ferris RL, Westra WH, Gilbert J, Bauman JE, Wagner LI, et al. E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with hpv-associated resectable squamous cell carcinoma of the oropharynx- ECOG-ACRIN cancer research group. J Clin Oncol. 2017;35(5):490–497. doi:10.1200/JCO.2016.68.3300.
   PubMed Web of Science ®Google Scholar
• Maxwell JH, Grandis JR, Ferris RL. HPV-associated head and neck cancer: unique features of epidemiology and clinical management. Annu Rev Med. 2016;67:91–101. doi:10.1146/annurev-med-051914-021907.
   PubMed Web of Science ®Google Scholar
• FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356(19):1915–1927. doi: 10.1056/NEJMoa061741.
   PubMed Web of Science ®Google Scholar
• Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30(Suppl 5):F123–138. doi:10.1016/j.vaccine.2012.04.108.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, D’Souza G, Gillison ML, Katki HA. Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. population. Oral Oncol. 2016;60:61–67. doi:10.1016/j.oraloncology.2016.06.006.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Graubard BI, Broutian T, Pickard RKL, Tong Z-Y, Xiao W, Kahle L, Gillison ML. Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J Clin Oncol. 2018;36(3):262–267. doi:10.1200/JCO.2017.75.0141.
   PubMed Web of Science ®Google Scholar
• Patton LL, Ashe TE, Elter JR, Southerland JH, Strauss RP. Adequacy of training in oral cancer prevention and screening as self-assessed by physicians, nurse practitioners, and dental health professionals. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(6):758–764. doi:10.1016/j.tripleo.2005.10.072.
   PubMed Web of Science ®Google Scholar
• Datema FR, Ferrier MB, van der Schroeff MP, Baatenburg de Jong RJ. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients. Head Neck. 2010;32(6):728–736.
   PubMed Web of Science ®Google Scholar
• Head and Neck Cancer: Statistics Cancer.net. Head and Neck Cancer Guide. 2018 [accessed 2018 Aug 18]. https://www.cancer.net/cancer-types/head-and-neck-cancer/statistics.
   Google Scholar
• Hapner ER, Bauer KL, Wise JC. The impact of a community-based oral, head and neck cancer screening for reducing tobacco consumption. Otolaryngol Head Neck Surg. 2011;145(5):778–782. doi:10.1177/0194599811415804.
   PubMed Web of Science ®Google Scholar
• Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol. 2009;21(3):194–200. doi:10.1097/CCO.0b013e32832a68ca.
   PubMed Web of Science ®Google Scholar
• Jackler RK, Samji HA. The price paid: manipulation of otolaryngologists by the tobacco industry to obfuscate the emerging truth that smoking causes cancer. Laryngoscope. 2012;122(1):75–87. doi:10.1002/lary.22358.
   PubMed Web of Science ®Google Scholar
• Shimpi N, Jethwani M, Bharatkumar A, Chyou PH, Glurich I, Acharya A. Patient awareness/knowledge towards oral cancer: a cross-sectional survey. BMC Oral Health. 2018;18(1):86. doi:10.1186/s12903-018-0507-5.
   PubMed Web of Science ®Google Scholar
• Patton LL, Agans R, Elter JR, Southerland JH, Strauss RP, Kalsbeek WD. Oral cancer knowledge and examination experiences among North Carolina adults. J Public Health Dent. 2004;64(3):173–180.
   PubMed Web of Science ®Google Scholar
• Osazuwa-Peters N, Adjei Boakye E, Mohammed KA, Tobo BB, Geneus CJ, Schootman M. Not just a woman’s business! Understanding men and women’s knowledge of HPV, the HPV vaccine, and HPV-associated cancers. Prev Med. 2017;99:299–304. doi:10.1016/j.ypmed.2017.03.014.
   PubMed Web of Science ®Google Scholar
• Lechner M, Vassie C, Kavasogullari C, Jones O, Howard J, Masterson L, Fenton T, Yarbrough W, Waller J, Gilson R. A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK. BMJ open. 2018;8(7):e023339. doi:10.1136/bmjopen-2018-023339.
   PubMed Web of Science ®Google Scholar
• Williams MU, Carr MM, Goldenberg D. Public awareness of human papillomavirus as a causative factor for oropharyngeal cancer. Otolaryngol Head Neck Surg. 2015;152(6):1029–1034. doi:10.1177/0194599815577781.
   PubMed Web of Science ®Google Scholar
• Luryi AL, Yarbrough WG, Niccolai LM, Roser S, Reed SG, Nathan C-AO, Moore MG, Day T, Judson BL. Public awareness of head and neck cancers: a cross-sectional survey. JAMA Otolaryngol Head & Neck Surg. 2014;140(7):639–646. doi:10.1001/jamaoto.2014.867.
   PubMed Web of Science ®Google Scholar
• AHNS Prevantion & Early Detection Committee. AHNS Response ot USPSTF Recommendation for screening of oral and oropharyngeal cancer. 2014 [accessed 2018 Aug 18]. https://www.ahns.info/wp-content/uploads/2016/12/AHNS-response-to-USPSTF.pdf.
   Google Scholar
• Position Statement on Human Papillomavirus (HPV) Vaccination for Prevention of HPV-Related Oropharyngeal Cancer. 2016; accessed 2018 Jul 8. https://www.ahns.info/wp-content/uploads/2015/10/HPV-Position-Statement-10-9-2015.pdf.
   Google Scholar
• Jackowska J, Bartochowska A, Karlik M, Wichtowski M, Tokarski M, Wierzbicka M. The knowledge of the role of papillomavirus-related head and neck pathologies among general practitioners, otolaryngologists and trainees. a survey-based study. PloS one. 2015;10(10):e0141003. doi:10.1371/journal.pone.0141003.
   PubMed Web of Science ®Google Scholar
• D’Souza G, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol. 2017;28(12):3065–3069. doi:10.1093/annonc/mdx535.
   PubMed Web of Science ®Google Scholar
• D’Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med. 2011;53(Suppl 1):S5–S11. doi:10.1016/j.ypmed.2011.08.001.
   PubMed Web of Science ®Google Scholar
• Khariwala SS, Moore MG, Malloy KM, Gosselin B, Smith RV. The “HPV Discussion”: effective use of data to deliver recommendations to patients impacted by HPV. Otolaryngol Head Neck Surg. 2015;153(4):518–525. doi:10.1177/0194599815597200.
   PubMed Web of Science ®Google Scholar
• Baxi SS, Shuman AG, Corner GW, Shuk E, Sherman EJ, Elkin EB, Hay JL, Pfister DG. Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to know. Head Neck. 2013;35(11):1534–1541. doi:10.1002/hed.v35.11.
   PubMed Web of Science ®Google Scholar
• Pagliusi SR, Teresa Aguado M. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine. 2004;23(5):569–578.
   PubMed Web of Science ®Google Scholar
• Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagué X, Skinner SR, Apter D, Naud P, Salmerón J, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13(1):89–99. doi:10.1016/S1470-2045(11)70286-8.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401–411. doi:10.1056/NEJMoa0909537.
   PubMed Web of Science ®Google Scholar
• Levi AW, Kelly DP, Rosenthal DL, Ronnett BM. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods. Cancer. 2003;99(4):191–197. doi:10.1002/cncr.11507.
   PubMed Web of Science ®Google Scholar
• Gillison ML, Broutian T, Pickard RK, Tong Z-Y, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States, 2009-2010. Jama. 2012;307(7):693–703. doi:10.1001/jama.2012.101.
   PubMed Web of Science ®Google Scholar
• Ahn SM, Chan JY, Zhang Z, Wang H, Khan Z, Bishop JA, Westra W, Koch WM, Califano JA. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. JAMA Otolaryngol Head & Neck Surg. 2014;140(9):846–854. doi:10.1001/jamaoto.2014.1338.
   PubMed Web of Science ®Google Scholar
• Rettig EM, Wentz A, Posner MR, Gross ND, Haddad RI, Gillison ML, Fakhry C, Quon H, Sikora AG, Stott WJ, et al. Prognostic implication of persistent human papillomavirus type 16 DNA detection in oral rinses for human papillomavirus-related oropharyngeal carcinoma. JAMA Oncol. 2015;1(7):907–915. doi:10.1001/jamaoncol.2015.2524.
   PubMed Web of Science ®Google Scholar
• Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP). 2011. MMWR Morbid Mortal Weekly Rep. 2011;60(50):1705–1708.
   PubMedGoogle Scholar
• Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2017. MMWR Morbid Mortal Weekly Rep. 2018;67(33):909–917. doi:10.15585/mmwr.mm6733a1.
   PubMed Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2016. MMWR Morbid Mortal Weekly Rep. 2017;66(33):874–882. doi:10.15585/mmwr.mm6633a2.
   PubMed Web of Science ®Google Scholar
• Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Prac Res Clin Obstet Gynaecol. 2018;47:14–26. doi:10.1016/j.bpobgyn.2017.08.006.
   PubMed Web of Science ®Google Scholar
• Malloy KM, Ellender SM, Goldenberg D, Dolan RW. A survey of current practices, attitudes, and knowledge regarding human papillomavirus-related cancers and vaccines among head and neck surgeons. JAMA Otolaryngol Head & Neck Surg. 2013;139(10):1037–1042. doi:10.1001/jamaoto.2013.4452.
   PubMed Web of Science ®Google Scholar
• Gnagi SH, Gnagi FT, Schraff SA, Hinni ML. Human papillomavirus vaccination counseling in pediatric training: are we discussing otolaryngology-related manifestations? Otolaryngol Head Neck Surg. 2016;155(1):87–93. doi:10.1177/0194599816639932.
   PubMed Web of Science ®Google Scholar
• Novakovic D, Cheng ATL, Zurynski Y, Booy R, Walker PJ, Berkowitz R, Harrison H, Black R, Perry C, Vijayasekaran S, et al. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. 2018;217(2):208–212. doi:10.1093/infdis/jix498.
   PubMed Web of Science ®Google Scholar
• Mauz PS, Schafer FA, Iftner T, Gonser P. HPV vaccination as preventive approach for recurrent respiratory papillomatosis - a 22-year retrospective clinical analysis. BMC Infect Dis. 2018;18(1):343. doi:10.1186/s12879-018-3109-6.
   PubMed Web of Science ®Google Scholar